https://www.selleckchem.com/products/hro761.html
At the end of the six-month submission period, 16 articles (15 research article and one review) were accepted after the peer-review processes and published online.Novel imidazole derivatives were designed, prepared, and evaluated in vitro for antitumor activity. The majority of the tested derivatives showed improved antiproliferative activity compared to the positive control drugs 5-FU and MTX. Among them, compound 4f exhibited outstanding antiproliferative activity against three cancer cell lines and was considerably more potent than bo
Mi piace
Commento
Condividi
